Cargando…
Pre-existing low-frequency resistance mutations increase the risk of antiretroviral treatment failure in HIV-1 naïve patients
Autores principales: | Su, Yifan, Cai, Rentian, Zhu, Yinyin, Zhong, Mingli, Qi, Mingxue, Chen, Chen, Ye, Zi, Zhang, Hongying, Wei, Hongxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684206/ https://www.ncbi.nlm.nih.gov/pubmed/37914679 http://dx.doi.org/10.1097/CM9.0000000000002901 |
Ejemplares similares
-
A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, China
por: Zhong, Mingli, et al.
Publicado: (2023) -
Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021
por: Su, Yifan, et al.
Publicado: (2023) -
Antiretroviral therapy-naïve people living with HIV tend to have more severe symptoms of COVID-19
por: Sun, Jinfeng, et al.
Publicado: (2023) -
Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder
por: Kim, Jin Un, et al.
Publicado: (2020) -
Is SARS-CoV-2 Infection a Risk for Potentiation of Epileptic Seizures in Children With Pre-existing Epilepsy?
por: Brisca, Giacomo, et al.
Publicado: (2021)